Table 1.
Embryonic developmental consequence of the patients with RTFF during assisted reproduction treatment.
| Clinical cycles | Patient with recurred Poly-PN zygotes | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oocyte | Oocyte | Fertilization | |||||||
| MII | MI | GV | Abnormal | 0PN | Poly-PN | ||||
| 1st | HMG+MPA+EE | ICSI | 11 | 5 | 3 | 2 | 1 | 1 | 4 |
| 2nd | HMG+MPA+CC | ICSI | 7 | 6 | 0 | 1 | 0 | 1 | 5 |
| Patient with recurred PN-arrest zygotes | |||||||||
| Oocyte | Fertilization | ||||||||
| Total | MII | MI | GV | Abnormal | 2PN | PN arrest | |||
| 1st | Short protocol | IVF/ICSI | 19 | 9/9 | 0 | 0 | 1 | 9/9 | 18 |
| 2nd | HMG + MPA | ICSI | 8 | 7 | 0 | 0 | 1 | 7 | 7 |
| 3rd | HMG + CC | ICSI | 10 | 9 | 0 | 1 | 0 | 9 | 9 |